1cP-LSD: Difference between revisions
>Mind at Large Removed hyphen |
>Edd →Legal status: the legal status changed in Germany. 1cP-LSD is now under the NpSG. |
||
Line 183: | Line 183: | ||
{{LegalStub}} | {{LegalStub}} | ||
*'''Germany''': 1cP-LSD is | *'''Germany''': 1cP-LSD is controlled under the NpSG (''New Psychoactive Substances Act'')<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> as of July 2, 2021.<ref>{{Cite web|access-date=September 16, 2021|language=de|pages=2231–2243|publication-date=July 2, 2021|publisher=Bundesanzeiger Verlag|title=Zweite Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl121s2231.pdf|work=Bundesgesetzblatt Jahrgang 2021 Teil I Nr. 38}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]|access-date=September 16, 2021|language=de}}</ref> | ||
*'''Japan''': 1cP-LSD is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>{{cite web|title=指定薬物を指定する省令が公布されました|language=ja|url=https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20210122-1.html|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|access-date=March 25, 2021}}</ref> | *'''Japan''': 1cP-LSD is controlled by the Pharmaceutical Affairs Law in Japan, making it illegal to possess or sell.<ref>{{cite web|title=指定薬物を指定する省令が公布されました|language=ja|url=https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/oshirase/20210122-1.html|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|access-date=March 25, 2021}}</ref> | ||
*'''Sweden''': Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.<ref>{{cite web|url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/december/tjugotre-amnen-foreslas-klassas-som-narkotika-eller-halsofarlig-vara/|title=Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara | trans-title = Twenty-three substances are proposed to be classified as drugs or dangerous goods |publisher=Folkhälsomyndigheten [Public Health Agency of Sweden]|language=sv|date=December 18, 2019|access-date=July 14, 2020}}</ref> | *'''Sweden''': Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.<ref>{{cite web|url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2019/december/tjugotre-amnen-foreslas-klassas-som-narkotika-eller-halsofarlig-vara/|title=Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara | trans-title = Twenty-three substances are proposed to be classified as drugs or dangerous goods |publisher=Folkhälsomyndigheten [Public Health Agency of Sweden]|language=sv|date=December 18, 2019|access-date=July 14, 2020}}</ref> |